Immuron (IMRN) EBIT (2016 - 2024)
Immuron's (IMRN) quarterly EBIT came in at -$1.7 million in Q4 2024, up 17.81% year-on-year from -$1.4 million in Q1 2024, and up 17.81% quarter-over-quarter from -$2.0 million in Q4 2023.
Immuron (IMRN) EBIT (2016 - 2024) Analysis & Trends
Immuron's EBIT history runs 9 years deep, the most recent figure standing at -$1.7 million for Q4 2024.
- On a quarterly basis, EBIT rose 17.81% year-over-year to -$1.7 million in Q4 2024; TTM through Dec 2024 was -$5.3 million, a 45.42% decrease from a year earlier, with the FY2025 full-year figure at -$3.5 million, up 8.95% from the prior year.
- EBIT improved to -$1.7 million in Q4 2024 per IMRN's latest filing, from -$2.0 million in the prior quarter.
- Across five years, EBIT topped out at -$13326.4 in Q4 2021 and bottomed at -$2.0 million in Q4 2023.
- The 5-year median for EBIT is -$796270.0 (2022), against an average of -$890587.5.
- Across the five-year window, EBIT jumped 76.77% in 2021 and plunged 2546.58% in 2022, its largest moves.
- Year by year, EBIT stood at -$57371.6 in 2020, then soared by 76.77% to -$13326.4 in 2021, then plunged by 2546.58% to -$352692.6 in 2022, then plunged by 472.74% to -$2.0 million in 2023, then advanced by 17.81% to -$1.7 million in 2024.
- Per Business Quant, the three latest IMRN EBIT figures stand at -$1.7 million (Q4 2024), -$2.0 million (Q4 2023), and -$1.2 million (Q2 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 249.90 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 394.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -445.22 Mn |
| 10 | Immuron | 255.19 Mn | 243.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1.66 Mn |
| Dec 31, 2023 | -2.02 Mn |
| Jun 30, 2023 | -1.24 Mn |
| Dec 31, 2022 | -352,692.59 |
| Dec 31, 2021 | -13,326.36 |
| Dec 31, 2020 | -57,371.61 |
| Dec 31, 2019 | -15,191.40 |
| Dec 31, 2018 | -1.58 Mn |
| Dec 31, 2017 | 3.84 Mn |
| Dec 31, 2016 | 2.55 Mn |
| Jun 30, 2016 | 4.33 Mn |